Sahm Adrangi Becoming a Force to Reckon with In the Investment Sector

Sahm Adrangi Becoming a Force to Reckon with In the Investment Sector

Sahm Adrangi Becoming a Force to Reckon with In the Investment Sector

 

Sahm Adrangi is a reputed short seller and research publisher. He is also the founder and CEO of Kerrisdale Capital Management a New York based company. Kerrisdale Capital was founded in 2009 and it is a key advocate of soft activism investment strategy and tries to create catalysts by sharing investment ideas with the world. This has been possible thanks to Sahm experience in the investment sector and his education background.

 

Adrangi is a Bachelor of Arts in Economics degree holder from the Yale University. Before founding and managing Kerrisdale Capital Management, Adrangi worked at Longacre Fund Management as an investment analyst. He was in charge of investment analysis and research in the equity and credit fund division in the organization. He also worked at Chanin Capital Partners a bankruptcy restructuring group before joining Longacre Fund Management. Prior to joining Chanin Capital Partners, he helped Deutsche Bank structure and collect non-investment grade bank debt and controlled buy-out financings.

Sahm Adrangi Investment Activism

Adrangi has played great roles in enlightening investors not only in New York, but also in many parts of the world. He has been a speaker at numerous conferences and an investment activist. New York Times, Wall Street Journal and major publications have also featured Mr. Adrangi in their work. His role in value investing conference as well as Distressed Debt investing conferences has also been profound.

Adrangis activism in the investment sector has led to the now famous line “Sahm Adrangi Negative Report.” This is a short position common in short selling and research publishing that Adrangi has used to address numerous investment issues. He published a negative report explaining in short how he does not approve QuinStreet, Inc. despite its stock quadrupling recently. According to Kerrisdale, the company manager doubts the sustainability and quality of the QuinStreet firm arguing that it has benefited from bogus web traffic.

 

Other companies that Adrangi and his Kerrisdale Capital Management have published negative reports explaining his short outlook include The St.Joe Company and Proteostasis Therapeutics among others. This report and research is shared in Kerrisdale website, social media and investment related websites.

 

http://www.zerohedge.com/news/2017-05-09/kerrisdale-capital-reveals-latest-short-selling-target-will-it-be-next-straight-path